|
Home
Search
Study Topics
Glossary
|
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
|
![]() |
![]() |
![]() |
|
![]() |
![]() |
|||||||||||||||||||||||||||||||||||||||||||||
| Found 90 studies with search of: | Abacavir/Lamivudine OR Epzicom[TREATMENT] AND HIV [CONDITION] |
| Rank | Status | Study | ||||
|---|---|---|---|---|---|---|
| 1 | Active, not recruiting |
Pilot Study With Isentress (Raltegravir) and Epzicom (Abacavir/Lamivudine) in Treatment Naive HIV-Infected Subjects
|
||||
| 2 |
Completed Has Results |
Abacavir/Lamivudine Versus Emtricitabine/Tenofovir Both In Combination With Lopinavir/Ritonavir For The Treatment Of HIV
|
||||
| 3 | Active, not recruiting |
A Randomized, Prospective Study of the Efficacy, Safety and Tolerability of Two Doses of GW433908Ritonavir Given With Abacavir/Lamivudine Fixed Dose Combination
|
||||
| 4 | Completed |
Pharmacokinetic Study Of EPZICOM Tablet
|
||||
| 5 | Active, not recruiting |
A Study in Underrepresented Patient Population or Regimen Tolerability: SUPPoRT
|
||||
| 6 | Completed |
A HIV Study Of A Fixed-Dose Combination Tablet In Antiretroviral Experienced Patients
|
||||
| 7 | Recruiting |
Comparison of Epzicom and Truvada for the Initial Once Daily HIV Treatment
|
||||
| 8 | Active, not recruiting |
KIVEXA Vs TRUVADA, Both Administered With Efavirenz, In ART-Naive Subjects
|
||||
| 9 | Active, not recruiting |
Efavirenz or Atazanavir/Ritonavir Given With Emtricitabine/Tenofovir Disoproxil Fumarate or Abacavir/Lamivudine in HIV Infected Treatment-Naive Adults
|
||||
| 10 | Active, not recruiting |
Induction/Simplification With Atazanavir + Ritonavir + Abacavir/Lamivudine Fixed-Dose Combination In HIV-1 Infection
|
||||
| 11 | Recruiting |
Artery Elasticity After Switch From Epzicom to Truvada
|
||||
| 12 | Completed |
KALETRA Or LEXIVA With Ritonavir Combined With EPIVIR And Abacavir In Naive Subjects Over 48 Weeks
|
||||
| 13 | Not yet recruiting |
Raltegravir + ABC/3TC in HIV/TB Co-Infected Patients
|
||||
| 14 | Completed |
A New Tablet Containing Two FDA-Approved Drugs In HIV-Infected Patients Who Have Not Received Prior Therapy
|
||||
| 15 | Completed |
New Tablet Containing Two FDA Approved Anti-HIV Drugs For Antiretroviral Therapy Experienced HIV-1 Infected Subjects
|
||||
| 16 | Recruiting |
Safety and Efficacy Study of Switching From Epzicom to Truvada
|
||||
| 17 | Recruiting |
A Randomised, Open-Label Trial to Assess the Safety and Efficacy of Switching to Tenofovir-Emtricitabine or Abacavir-Lamivudine: The STEAL Study
|
||||
| 18 | Recruiting |
Lopinavir/r Monotherapy Versus Abacavir/Lamivudine and Lopinavir/r for Limb Fat Recovery in Persons With Lipoatrophy
|
||||
| 19 | Completed |
A Study Comparing Safety Of Abacavir And Lamivudine Administered Once-Daily As A Single Tablet Versus The Same Drugs Administered Twice-Daily As Separate Tablets (ALOHA Study)
|
||||
| 20 | Completed |
Study Of Investigational Regimen Combining FDA Approved HIV Drugs In HIV Subjects Experiencing Early Virologic Failure
|
|
Previous Page | Studies Shown (1-20) | Next Page (21-40) |
|